Skip to main content
. 2020 Nov 17;10:19997. doi: 10.1038/s41598-020-77095-x

Figure 4.

Figure 4

Pharmacokinetics analysis of TRAIL, TRAIL-ATNC, and TRAIL-ATNCIL4rP. Proteins were injected into mice using retro orbital injection (n = 3 for each protein). (AC) Relative serum concentrations of native TRAIL (A), TRAIL-ATNC (B), and TRAIL-ATNCIL4rP (C) were evaluated at periodic intervals by western blotting with an antibody against human TRAIL (Protein, estimated total amount of each proteins; Control serum, serum derived from the untreated mice). The quantification of the amount of TRAIL proteins present in each sample was done using Image J program. (DF) Estimated half-lives (T1/2) of TRAIL (D), TRAIL-ATNC (E), and TRAIL-ATNCIL4rP (F) were calculated using GraphPad Prism v7.0. Error bars represent ± SEM.